Hai cercato la traduzione di lipoatrofija da Maltese a Inglese

lipoatrofija
lipoatrophy

indrome ta’ lipoatrofija
lipoatrophy

lipodistrofija (lipoatrofija/ lipomatożi):
lipodystrophy (lipoatrophy/ lipomatosis):

alopeċja, ġilda xotta, ekżema, lipoatrofija, ħakk, raxx
alopecia, dry skin, eczema, lipoatrophy, pruritus, rash

mhux komuni: eksantema, lipoatrofija, lipodistrofija miksuba, lipoipertrofija.
uncommon: exanthem, lipoatrophy, lipodystrophy acquired, lipohypertrophy.

Ġiet ipotiżżata konnessjoni bejn lipomatożi vixxerali u pis u lipoatrofija u nrtis.
100 between visceral lipomatosis and pis and lipoatrophy and nrtis has been hypothesised.

is-sit tat-tilqima għandu jinbidel biex ma jkunx hemm lipoatrofija.
the injection site should be varied to prevent lipoatrophy.

lipodistrofija miksuba, alopeċja, ġilda xotta, ekżema, lipoatrofija, ħakk, raxx
acquired lipodystrophy, alopecia, dry skin, eczema, lipoatrophy, pruritus, rash

il- postijiet ta 'l- injezzjoni għandhom jitbiddlu sabiex tiġi evitata lipoatrofija.
the injection sites should be varied in order to avoid lipo-atrophy.

lipodistrofija, (inkluż lipoipertrofija, lipodistrofija, lipoatrofija), ipertrigliserajdimja, iperkolesterolimja, iperlipidimja
uncommon

l-inċidenza u s-severità ta’ lipoatrofija huma relatati ma’ espożizzjoni kumulattiva.
the incidence and severity of lipoatrophy are related to cumulative exposure.

it-terapija għandha tinqaleb għal kors alternattiv jekk ikun hemm suspett ta’ żvilupp ta’ lipoatrofija.
therapy should be switched to an alternative regimen if there is suspicion of lipoatrophy development.

tista’ sseħħ lipodistrofija (fosthom lipoipertrofija, lipoatrofija) fis-sit tal-injezzjoni.
lipodystrophy (including lipohypertrophy, lipoatrophy) may occur at the injection site.

il-lipodistrofija (fosthom lipoipertrofija, lipoatrofija) tista’ sseħħ fis-sit tal-injezzjoni.
lipodystrophy (including lipohypertrophy, lipoatrophy) may occur at the injection site.

xi nrtis, bħal stavudine, kienu assoċjati ma 'telf fix- xaħam tal- ġisem (lipoatrofija).
some nrtis, such as stavudine, have been associated with a loss of body fat (lipoatrophy).

il-lipodistrofija (fosthom lipoipertrofija, lipoatrofija) tista’ sseħħ fis-sit ta’ l-injezzjoni.
lipodystrophy (including lipohypertrophy, lipoatrophy) may occur at the injection site.

il-lok tat-teħid tal-injezzjoni ta’ taħt il-ġilda għandu jinbidel sabiex tkun evitata l-lipoatrofija.
the subcutaneous injection site should be alternated to prevent lipoatrophy.

l-injezzjoni għandha tingħata taħt il-ġilda u s-sit ta’ l-injezzjoni jinbidel biex tiġi evitata l-lipoatrofija.
the injection should be given subcutaneously and the site varied to prevent lipoatrophy.

konnessjoni bejn lipomatożi vixxerali u inibituri tal- protease (pis) u lipoatrofija u inibituri ta ’ nucleoside reverse transcriptase (nrtis) ġie ipotizzat.
a connection between visceral lipomatosis and protease inhibitors (pis) and lipoatrophy and nucleoside reverse transcriptase inhibitors (nrtis) has been hypothesised.